Your browser doesn't support javascript.
loading
Spike-directed vaccination elicits robust spike-specific T-cell response, including to mutant strains.
Stanojevic, Maja; Geiger, Ashley; Ostermeier, Brita; Sohai, Danielle; Lazarski, Christopher; Lang, Haili; Jensen-Wachspress, Mariah; Webber, Kathleen; Burbelo, Peter; Cohen, Jeffrey; Keller, Michael D; Bollard, Catherine M; Cruz, Conrad Russell Y.
Afiliação
  • Stanojevic M; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Geiger A; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Ostermeier B; Institute for Biomedical Sciences, George Washington University, Washington, DC, USA.
  • Sohai D; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Lazarski C; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Lang H; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Jensen-Wachspress M; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Webber K; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Burbelo P; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
  • Cohen J; National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
  • Keller MD; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA.
  • Bollard CM; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA. Electronic address: cbollard@childrensnational.org.
  • Cruz CRY; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA. Electronic address: ccruz@childrensnational.org.
Cytotherapy ; 24(1): 10-15, 2022 01.
Article em En | MEDLINE | ID: mdl-34483067
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Cytotherapy Assunto da revista: TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Cytotherapy Assunto da revista: TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos